Cite
HARVARD Citation
Paul, F. et al. (2023). P-59 Association of B cell subsets and aquaporin-4 antibody titers with disease activity in participants in the N-MOmentum trial receiving inebilizumab treatment. Clinical neurophysiology. pp. e35-. [Online].